This article provides an evidence-based update on new therapies available for the management of type 2 diabetes.
Written by A/Prof Michael D’Emden MBBS, PHD, FRACP
A/Prof d’Emden is the Director of the Department of Endocrinology and Diabetes at The Royal Brisbane and Women’s Hospital. He is the Former Vice President of the Australian Diabetes Society and has been involved in many clinical trials including DECLARE, EMPA-REG, CAROLINA. A/Prof d’Emden is a Management Committee Member of ASPEN, FIELD and TNT studies.
Listen to expert interviews.
Click to open in a new tab
PodcastsBrowse the latest monographs from Healthed.
Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.
Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.
